GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Implantica AG (STU:8IM1) » Definitions » EPS (Diluted)

Implantica AG (STU:8IM1) EPS (Diluted) : € (TTM As of . 20)


View and export this data going back to 2020. Start your Free Trial

What is Implantica AG EPS (Diluted)?

Implantica AG's Earnings per Share (Diluted) for the six months ended in . 20 was €0.00.

Implantica AG's EPS (Basic) for the six months ended in . 20 was €0.00.

Implantica AG's EPS without NRI for the six months ended in . 20 was €0.00.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.


Implantica AG EPS (Diluted) Historical Data

The historical data trend for Implantica AG's EPS (Diluted) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Implantica AG EPS (Diluted) Chart

Implantica AG Annual Data
Trend
EPS (Diluted)

Implantica AG Semi-Annual Data
EPS (Diluted)

Competitive Comparison of Implantica AG's EPS (Diluted)

For the Medical Devices subindustry, Implantica AG's PE Ratio, along with its competitors' market caps and PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Implantica AG's PE Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Implantica AG's PE Ratio distribution charts can be found below:

* The bar in red indicates where Implantica AG's PE Ratio falls into.



Implantica AG EPS (Diluted) Calculation

EPS (Diluted) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Diluted EPS takes into account all of the outstanding dilutive securities that could potentially be exercised (such as stock options and convertible preferred stock) and shows how such an action would impact earnings per share.

Implantica AG's Diluted EPS for the fiscal year that ended in . 20 is calculated as

Diluted EPS (A: . 20 ) = (Net Income - Preferred Dividends) / Shares Outstanding (Diluted Average)
=(-)/0
=

Implantica AG's Diluted EPS for the quarter that ended in . 20 is calculated as



Implantica AG  (STU:8IM1) EPS (Diluted) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.


Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.


Implantica AG EPS (Diluted) Related Terms

Thank you for viewing the detailed overview of Implantica AG's EPS (Diluted) provided by GuruFocus.com. Please click on the following links to see related term pages.


Implantica AG Business Description

Comparable Companies
Traded in Other Exchanges
Address
Aeulestrasse 45, Vaduz, LIE, 9490
Implantica AG is a medtech group providing effective care for serious health conditions and improving patients' quality of life by bringing advanced technology into the body. The therapies Implantica develops are based on implants that are medical devices inserted into the patient's body and are intended to remain in place permanently or semi-permanently, using electrical power provided by a battery. The company has developed a broad, patent-protected, product pipeline based partly on its two platform technologies. To bring advanced technology into the body, and adequate energy supply is required which would require very large batteries, so, Implantica has developed a wireless energising platform to supply energy to the body through intact skin.

Implantica AG Headlines

No Headlines